官方服务：
资源简介：
Glatiramer acetate complexed with CpG as intratumoral immunotherapy in combination with anti-PD1
应用场景：
创建时间：
2022-08-26
相关数据集
Local thermal ablation breaks immune tolerance in pacreatic cancer [RNA-seq 1]. Local thermal ablation breaks immune tolerance in pacreatic cancer [RNA-seq 1]
Pancreatic cancer (PC) is a devastating disease characterised by late diagnosis, genetic neoplastic heterogeneity, poor T-cell infiltration, a highly immunosuppressive tumour microenvironment, and met
NIAID Data Ecosystem60
Aurora A Kinase Inhibition Induces Accumulation of Tumor Cells in Mitosis with Restored Interferon Signaling to Potentiate Response to PD-L1 Immune Checkpoint Blockade [RNA-seq]
By arresting tumor cells in mitosis, aurora A kinase inhibition restores interferon signaling in small cell lung cancer tumor cells and cooperates with PD-L1 immune checkpoint blockade. Bulk RNA seque
NIAID Data Ecosystem30
The anti-tumor effects of Low-dose Radiotherapy Combined with Dual PD-L1 and VEGFA Blockade in Hepatocellular Carcinoma. Mus musculus
To explore the synergistic effect of low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade to improve the prognosis of patients with HCC.
NIAID Data Ecosystem00
Supplementary table from Paradigms on Immunotherapy Combinations with Chemotherapy
Supplementary information regarding chemoimmunotehrapy clinical trials other than phase III or ongoing.
Figshare2021-06-01 更新50
Sequential JAK inhibition boosts antitumor T cell responses to combined anti-PD-1 and anti-CTLA4
While immune Checkpoint Inhibition (CPI) has reshaped cancer treatment, the majority of cancer patients do not benefit from this treatment approach, and this treatment can lead to immune related adver
NIAID Data Ecosystem20
